$INCY
INCYTE CORP

2022 Q3 Form 10-Q Financial Statement

#000155837022011631 Filed on August 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $823.3M $911.4M $733.2M
YoY Change 1.27% 29.15% 21.25%
Cost Of Revenue $54.58M $50.64M $42.61M
YoY Change 36.91% 33.15% 45.84%
Gross Profit $768.7M $860.8M $690.6M
YoY Change -0.57% 28.92% 20.0%
Gross Profit Margin 93.37% 94.44% 94.19%
Selling, General & Admin $266.5M $253.3M $209.6M
YoY Change 39.72% 49.99% 36.27%
% of Gross Profit 34.66% 29.42% 30.35%
Research & Development $384.0M $347.2M $353.4M
YoY Change 14.65% 1.07% 15.14%
% of Gross Profit 49.95% 40.34% 51.17%
Depreciation & Amortization $5.384M $16.51M $16.44M
YoY Change -63.35% 13.88% 18.79%
% of Gross Profit 0.7% 1.92% 2.38%
Operating Expenses $650.5M $600.5M $563.0M
YoY Change 23.75% 17.2% 22.2%
Operating Profit $138.4M $254.4M $116.5M
YoY Change -41.22% 80.66% 17.96%
Interest Expense $641.0K $678.0K $680.0K
YoY Change 46.01% 89.39% 89.42%
% of Operating Profit 0.46% 0.27% 0.58%
Other Income/Expense, Net $11.51M $522.0K $1.260M
YoY Change 491.02% -88.11% -189.55%
Pretax Income $148.6M $229.4M $70.54M
YoY Change -29.06% 33.64% 1.75%
Income Tax $35.80M $67.90M $32.50M
% Of Pretax Income 24.09% 29.6% 46.08%
Net Earnings $112.8M $161.4M $37.99M
YoY Change -37.95% 8.01% -29.03%
Net Earnings / Revenue 13.7% 17.71% 5.18%
Basic Earnings Per Share $0.51 $0.73 $0.17
Diluted Earnings Per Share $0.50 $0.72 $0.17
COMMON SHARES
Basic Shares Outstanding 222.4M 221.7M 221.3M
Diluted Shares Outstanding 224.2M shares 223.7M 223.0M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.977B $2.722B $2.544B
YoY Change 30.34% 30.82% 29.65%
Cash & Equivalents $2.691B $2.435B $2.257B
Short-Term Investments $286.5M $287.0M $287.4M
Other Short-Term Assets $179.9M $166.0M $146.1M
YoY Change 76.87% 96.98% 98.82%
Inventory $45.90M $54.50M $35.50M
Prepaid Expenses
Receivables $618.2M $683.0M $562.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.821B $3.626B $3.288B
YoY Change 30.69% 38.39% 34.21%
LONG-TERM ASSETS
Property, Plant & Equipment $715.7M $721.3M $729.2M
YoY Change 4.23% 9.07% 22.63%
Goodwill $155.6M $155.6M $155.6M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $149.1M $149.8M $174.7M
YoY Change -22.37% -32.13% -13.61%
Other Assets $23.67M $23.01M $31.42M
YoY Change -4.53% 12.53% -19.04%
Total Long-Term Assets $1.689B $1.693B $1.766B
YoY Change 32.48% 31.81% 45.78%
TOTAL ASSETS
Total Short-Term Assets $3.821B $3.626B $3.288B
Total Long-Term Assets $1.689B $1.693B $1.766B
Total Assets $5.510B $5.319B $5.054B
YoY Change 31.23% 36.22% 38.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.2M $194.8M $152.5M
YoY Change 42.5% 59.52% 79.34%
Accrued Expenses $699.8M $598.8M $609.3M
YoY Change 45.23% 44.97% 44.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $33.59M $3.036M $2.796M
YoY Change 1299.5% 26.08% 21.57%
Total Short-Term Liabilities $1.007B $926.7M $886.2M
YoY Change 35.53% 40.34% 42.04%
LONG-TERM LIABILITIES
Long-Term Debt $30.48M $31.16M $31.39M
YoY Change -2.87% -2.14% -2.53%
Other Long-Term Liabilities $74.68M $76.06M $69.47M
YoY Change 19.86% 32.07% 27.56%
Total Long-Term Liabilities $74.68M $76.06M $69.47M
YoY Change 19.86% 32.07% 27.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.007B $926.7M $886.2M
Total Long-Term Liabilities $74.68M $76.06M $69.47M
Total Liabilities $1.284B $1.234B $1.191B
YoY Change 22.22% 27.38% 27.59%
SHAREHOLDERS EQUITY
Retained Earnings -$465.7M -$578.5M -$739.9M
YoY Change -65.29% -62.03% -55.77%
Common Stock $4.721B $4.689B $4.626B
YoY Change 4.71% 4.73% 4.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.227B $4.085B $3.863B
YoY Change
Total Liabilities & Shareholders Equity $5.510B $5.319B $5.054B
YoY Change 31.23% 36.22% 38.04%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $112.8M $161.4M $37.99M
YoY Change -37.95% 8.01% -29.03%
Depreciation, Depletion And Amortization $5.384M $16.51M $16.44M
YoY Change -63.35% 13.88% 18.79%
Cash From Operating Activities $296.4M $174.2M $215.7M
YoY Change 16.18% 0.7% 4.68%
INVESTING ACTIVITIES
Capital Expenditures -$27.81M -$11.74M -$17.01M
YoY Change -13.5% -82.29% -64.64%
Acquisitions
YoY Change
Other Investing Activities -$591.0K -$737.0K $258.0K
YoY Change -1.66% -104.29% -102.21%
Cash From Investing Activities -$28.40M -$12.48M -$16.75M
YoY Change -13.29% -74.58% -71.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.31M 15.90M 96.00K
YoY Change -26.01% 328.14% -99.25%
NET CHANGE
Cash From Operating Activities 296.4M 174.2M 215.7M
Cash From Investing Activities -28.40M -12.48M -16.75M
Cash From Financing Activities -14.31M 15.90M 96.00K
Net Change In Cash 253.7M 177.6M 199.3M
YoY Change 24.96% 39.22% 27.07%
FREE CASH FLOW
Cash From Operating Activities $296.4M $174.2M $215.7M
Capital Expenditures -$27.81M -$11.74M -$17.01M
Free Cash Flow $324.2M $185.9M $232.7M
YoY Change 12.86% -22.29% -8.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
incy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate
0.05
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7217000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1308000
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Inventory Net
InventoryNet
27904000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
165950000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221084433
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
CY2021Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
CY2022Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
INCYTE CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000879169
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221875396
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12400
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3136539
dei Entity Address Address Line1
EntityAddressAddressLine1
1801 Augustine Cut-Off
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19803
dei City Area Code
CityAreaCode
302
dei Local Phone Number
LocalPhoneNumber
498-6700
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
dei Trading Symbol
TradingSymbol
INCY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
222430635
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2435381000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2057440000
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
292350000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
291871000
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
287044000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
290752000
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
682968000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
616300000
CY2022Q2 us-gaap Inventory Net
InventoryNet
54502000
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-282000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
126278000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
3625845000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3118674000
CY2022Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1644000
CY2021Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1720000
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
149784000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
221266000
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
39626000
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
29034000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
721328000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
723920000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27349000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27548000
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
139987000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
150755000
CY2022Q2 us-gaap Goodwill
Goodwill
155593000
CY2021Q4 us-gaap Goodwill
Goodwill
155593000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
434867000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
467538000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23012000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37304000
CY2022Q2 us-gaap Assets
Assets
5319035000
CY2021Q4 us-gaap Assets
Assets
4933352000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
194770000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
172110000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
93145000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
108962000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
598808000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533595000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3036000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2635000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
36915000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37006000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
926674000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
854308000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
200085000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
206994000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31157000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31632000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76058000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70414000
CY2022Q2 us-gaap Liabilities
Liabilities
1233974000
CY2021Q4 us-gaap Liabilities
Liabilities
1163348000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Revenues
Revenues
1310427000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
50636000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347196000
us-gaap Operating Income Loss
OperatingIncomeLoss
239633000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
522000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
221875396
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
221084433
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
222000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
221000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4688985000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4567111000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25696000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19454000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-578450000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-777874000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4085061000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3770004000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5319035000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4933352000
CY2022Q2 us-gaap Revenues
Revenues
911397000
CY2021Q2 us-gaap Revenues
Revenues
705709000
us-gaap Revenues
Revenues
1644632000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
38028000
us-gaap Cost Of Revenue
CostOfRevenue
93250000
us-gaap Cost Of Revenue
CostOfRevenue
67248000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
343511000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
700569000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
650407000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
253277000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
168859000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
462861000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
322654000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
3313000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4632000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9695000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10158000
CY2022Q2 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
2544000
CY2021Q2 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
9843000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
7286000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
20327000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
656966000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
564873000
us-gaap Costs And Expenses
CostsAndExpenses
1273661000
us-gaap Costs And Expenses
CostsAndExpenses
1070794000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
254431000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
140836000
us-gaap Operating Income Loss
OperatingIncomeLoss
370971000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Net Income Loss
NetIncomeLoss
199424000
us-gaap Net Income Loss
NetIncomeLoss
202991000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4187000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-165000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4390000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1782000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2983000
CY2022Q2 us-gaap Interest Expense
InterestExpense
678000
CY2021Q2 us-gaap Interest Expense
InterestExpense
358000
us-gaap Interest Expense
InterestExpense
1358000
us-gaap Interest Expense
InterestExpense
717000
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-24897000
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
26765000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-71482000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-944000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
229378000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171633000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
299913000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
240955000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67946000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22177000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100489000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37964000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
161432000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
149456000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221660000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220083000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221493000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219942000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223661000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222250000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223277000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222061000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
161432000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
149456000
us-gaap Net Income Loss
NetIncomeLoss
199424000
us-gaap Net Income Loss
NetIncomeLoss
202991000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1837000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1876000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2619000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3432000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1094000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-133000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
43509000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32945000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28295000
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1469
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-342000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-564000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-684000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2649000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2085000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6242000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2913000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
158783000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
151541000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
193182000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
200078000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3770004000
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
323582
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14237000
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1535
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44320000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3593000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
37992000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3863072000
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
274693
CY2022Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
189684
CY2022Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
16601000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
109000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46496000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
107114000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2649000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
161432000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4085061000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2611268000
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
389512
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20028000
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1357
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
108000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47903000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4998000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
53535000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2727844000
CY2021Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
390001
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
153082
CY2021Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
11016000
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1288
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
109000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45351000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2085000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
149456000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2935861000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
43988000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
102288000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29228000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-108898000
us-gaap Share Based Compensation
ShareBasedCompensation
90337000
us-gaap Share Based Compensation
ShareBasedCompensation
92090000
us-gaap Profit Loss
ProfitLoss
199424000
us-gaap Profit Loss
ProfitLoss
202991000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8952000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30823000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-32475000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
160000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8467000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3214000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-71482000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-944000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9695000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10158000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
66668000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-43824000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25380000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2981000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37190000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16287000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22660000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23333000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
51651000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6382000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
389898000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
379039000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
8662000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
9328000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
28749000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
114390000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
37692000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
43669000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6854000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12625000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1368000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1173000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
13473000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
13357000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15997000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16514000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1198000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2159000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
377865000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
284496000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2059160000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1514765000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2437025000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1799261000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
76464000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
35996000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2025000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
408000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.</i>  The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
911397000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
705709000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1644632000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1310427000
CY2022Q2 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
94128000
CY2021Q4 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
56938000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
721328000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219942000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
35750000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
723920000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
161432000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
149456000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22371000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
36317000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39895000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35440000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15768000
CY2022Q2 us-gaap Inventory Net
InventoryNet
54500000
CY2022Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
39600000
CY2022Q2 incy Inventory Recorded As Research And Development Expense
InventoryRecordedAsResearchAndDevelopmentExpense
66000000.0
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
913186000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899640000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191858000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175720000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
199424000
CY2022Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
209501000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
168412000
CY2022Q2 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
137445000
CY2021Q4 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
109486000
CY2022Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
141538000
CY2021Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
136541000
CY2022Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
34607000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9232776
CY2022Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
8952000
CY2021Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
27098000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9369000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10554000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57396000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45754000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
598808000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533595000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
90300000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
92100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes valuation model
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
202991000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3966888
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
84.91
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3847552
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
84.64
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10113298
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted
1964498
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled
1083976
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100500000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000000.0
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-569000000.0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
408200000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
9400000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221660000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220083000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221493000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
161432000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
149456000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
199424000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
202991000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221660000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220083000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221493000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219942000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2001000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2167000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1784000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2119000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223661000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222250000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223277000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222061000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4700000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9600000
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4300000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
8400000
CY2022Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2438000
CY2021Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1997000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
4960000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
3952000
CY2022Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
62000
CY2021Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
23000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
126000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
45000
CY2022Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1035000
CY2021Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
15000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2106000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
30000
CY2022Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
193000
CY2021Q2 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
387000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
108000
CY2022Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-89000
CY2021Q2 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-288000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-177000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-576000
CY2022Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1747000
CY2021Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2347000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3544000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
4651000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
6400000

Files In Submission

Name View Source Status
0001558370-22-011631-index-headers.html Edgar Link pending
0001558370-22-011631-index.html Edgar Link pending
0001558370-22-011631.txt Edgar Link pending
0001558370-22-011631-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
incy-20220630.xsd Edgar Link pending
incy-20220630x10q.htm Edgar Link pending
incy-20220630x10q_htm.xml Edgar Link completed
incy-20220630xex10d1.htm Edgar Link pending
incy-20220630xex31d1.htm Edgar Link pending
incy-20220630xex31d2.htm Edgar Link pending
incy-20220630xex32d1.htm Edgar Link pending
incy-20220630xex32d2.htm Edgar Link pending
incy-20220630_cal.xml Edgar Link unprocessable
incy-20220630_def.xml Edgar Link unprocessable
incy-20220630_lab.xml Edgar Link unprocessable
incy-20220630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending